Orchid Acquires Cam Bioceramics Coating Facility in Suzhou, China - Expands Coating Capability to Asia
Holt, MI, November 19, 2015 --(PR.com)-- Orchid Orthopedic Solutions (Orchid), a worldwide leader in design and manufacturing for the orthopedic and medical device industry, is pleased to announce it has signed an agreement to acquire the Cam Bioceramics coating facility and operations in Suzhou (Cam China), a high quality provider of hydroxylapatite (HA) plasma coatings in China. The transaction is expected to close in December of 2015.
The acquisition of the high quality coating facility in China further strengthens Orchid’s role as a global coating leader. Orchid can now offer world-class coating capabilities in the U.S., Europe and Asia to its customers. The acquisition also creates a base for Orchid to further expand its capabilities in China to serve the growing demands in the market.
“The acquisition of Cam China strongly commits Orchid to the market in Asia. We will continue to expand our manufacturing platform and coating capabilities in China to support the growing demand from our global and local customers,” said Christopher Norbye, Orchid’s International Executive Vice President, based in China.
”We are convinced that Orchid is the perfect company to continue the development of the operations and relationships we have built over the last four years in China and I am confident the team in China will have great opportunities to grow the business together with Orchid going forward,” said Gerard Kok, the founder and owner of Cam Bioceramics.
Cam Bioceramics is a global orthobiologic materials innovator specializing in calcium phosphates. By divesting its China coating facility to Orchid, Cam Bioceramics is focusing on its core business: the engineering, development and contract manufacturing of orthobiologic calcium compositions. The company is based in Leiden, the Netherlands and its Dutch ownership remains unchanged.
About Orchid Coatings
Orchid’s coating technology and experience extends 20+ years in the US and Europe, and is extended further with the new offerings in Asia. Orchid’s coatings and surface treatments now include spherical bead, Asymmatrix®, Osseomatrix®, titanium plasma spray, hydroxylapatite (HA), VPS on PEEK, VPS Ti on Polyethylene, ceramic coatings and Resorbable Blast Media (RBM).
About Orchid
Orchid is a worldwide leader in design and manufacturing for the orthopedic and medical device markets. Orchid is able to do this by compressing time to market, providing new technologies and being the best total supply-chain value. Besides coating technologies Orchid provides expertise in design and development, quality and regulatory support, implant manufacture, advanced machining, plastics technology, instrument manufacturing, and packaging services. With 14 world-class facilities located around the globe, Orchid continues to provide others an opportunity to live a better life through the products, services and the way the company does business. For more information about Orchid, visit the company’s website at www.orchid-ortho.com.
The acquisition of the high quality coating facility in China further strengthens Orchid’s role as a global coating leader. Orchid can now offer world-class coating capabilities in the U.S., Europe and Asia to its customers. The acquisition also creates a base for Orchid to further expand its capabilities in China to serve the growing demands in the market.
“The acquisition of Cam China strongly commits Orchid to the market in Asia. We will continue to expand our manufacturing platform and coating capabilities in China to support the growing demand from our global and local customers,” said Christopher Norbye, Orchid’s International Executive Vice President, based in China.
”We are convinced that Orchid is the perfect company to continue the development of the operations and relationships we have built over the last four years in China and I am confident the team in China will have great opportunities to grow the business together with Orchid going forward,” said Gerard Kok, the founder and owner of Cam Bioceramics.
Cam Bioceramics is a global orthobiologic materials innovator specializing in calcium phosphates. By divesting its China coating facility to Orchid, Cam Bioceramics is focusing on its core business: the engineering, development and contract manufacturing of orthobiologic calcium compositions. The company is based in Leiden, the Netherlands and its Dutch ownership remains unchanged.
About Orchid Coatings
Orchid’s coating technology and experience extends 20+ years in the US and Europe, and is extended further with the new offerings in Asia. Orchid’s coatings and surface treatments now include spherical bead, Asymmatrix®, Osseomatrix®, titanium plasma spray, hydroxylapatite (HA), VPS on PEEK, VPS Ti on Polyethylene, ceramic coatings and Resorbable Blast Media (RBM).
About Orchid
Orchid is a worldwide leader in design and manufacturing for the orthopedic and medical device markets. Orchid is able to do this by compressing time to market, providing new technologies and being the best total supply-chain value. Besides coating technologies Orchid provides expertise in design and development, quality and regulatory support, implant manufacture, advanced machining, plastics technology, instrument manufacturing, and packaging services. With 14 world-class facilities located around the globe, Orchid continues to provide others an opportunity to live a better life through the products, services and the way the company does business. For more information about Orchid, visit the company’s website at www.orchid-ortho.com.
Contact
Orchid
Abbie Woolston
517-694-2300
www.orchid-ortho.com
Abbie Woolston
517-694-2300
www.orchid-ortho.com
Contact
Categories